Taking Patient Care to the Next Level: Addressing the Clinical Challenges Impacting the Management of Dermatologic Conditions

Download these slides for an expert review of novel therapies, care transitions, and reducing health disparities in the management of moderate to severe atopic dermatitis.

Robert Sidbury, MD, MPH Benjamin Ungar, MD Released: September 9, 2022

Download these slides for an expert review of the diagnosis and treatment, including current and promising investigational therapies, for prurigo nodularis.

Benjamin Ungar, MD Released: September 9, 2022

Download these slides for an expert review of novel therapies, improved adherence, and reducing health disparities in the management of moderate to severe psoriasis.

Steven Feldman, MD, PhD Melodie S. Young, MSN, A/GNP-c Released: September 9, 2022

Download these slides for an expert review of the diagnosis and treatment, including current and promising investigational therapies, for chronic spontaneous urticaria.

Jonathan A. Bernstein, MD Released: September 9, 2022

Gain expert insights into the management of pustular psoriasis including emerging treatment options.

Alice Gottlieb, MD, PhD Kristine Kucera, PA-C, MPAS, DHSc Released: September 9, 2022

This expert commentary reviews strategies for incorporating novel therapies, addressing healthcare disparities, and transitions of care for patients with moderate to severe atopic dermatitis.

Robert Sidbury, MD, MPH Released: September 16, 2022

Chronic spontaneous urticaria (CSU) significantly impacts a patient’s physical and emotional health and appropriate management is essential for improving quality of life. In this expert commentary, Jonathan A. Bernstein, MD provides an overview of key concepts regarding the diagnosis and treatment CSU.

Jonathan A. Bernstein, MD Released: September 15, 2022

While prurigo nodularis (PN) may be a result of several underlying conditions, it is a distinct clinical entity that may persist despite removal of the underlying cause. Several promising agents in phase III trials may provide significant long-term relief.

Benjamin Ungar, MD Released: September 16, 2022

This expert commentary reviews strategies for incorporating new and emerging therapies, improving medication adherence, and addressing healthcare disparities, for patients with moderate to severe psoriasis.

Steven Feldman, MD, PhD Released: September 16, 2022

A diagnosis of life-threatening generalized pustular psoriasis (GPP) requires the exclusion of several other diagnoses presenting with pustules. In this commentary Alice Gottlieb, MD, PhD discusses the importance of an early and accurate diagnosis, which laboratory tests are helpful, and the newest, targeted treatment option available.

Alice Gottlieb, MD, PhD Released: September 17, 2022